Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 519 of 6351
-
Cell therapy Descartes-08 tested in teens with lupus and other autoimmune diseases
Disease control Recruiting nowSafety, tolerability and efficacy of Descarte-08 in children, adolescents and young adults with childhood-onset systemic lupus erythematosus, ANCA-associated vasculitis, juvenile myasthenia gravis, and juvenile dermatomyositis
Phase 1/2 • Sponsor: Cartesian Therapeutics • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Triple-Target CAR t cells take on tough blood cancers
Disease control OngoingThis phase I trial tests the safety, side effects and best dose of anti-CD19/20/22 chimeric antigen receptor (CAR) T cells (TriCAR19.20.22 T cells) and how well they work in treating patients with non-Hodgkin lymphoma, acute lymphoblastic leukemia (ALL) and chronic lymphocytic le…
Phase 1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New antibody shows promise against Post-Transplant virus threat
Disease control Not yet recruitingEBV DNAemia is defined as the presence of EBV-DNA load in peripheral blood exceeding the normal threshold, serving as a key diagnostic indicator for EBV-associated post-transplant lymphoproliferative disorder (EBV-PTLD). According to the European Conference on Infections in Leuke…
Phase 2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could classroom coaching be a key to teen mental Well-Being?
Prevention OngoingThe Solution-Focused Intervention for Mental Health (SIM) is a universal, school-based programme designed to promote mental well-being among adolescents. Previous feasibility and development studies have supported the acceptability and feasibility of SIM in upper-secondary school…
Sponsor: Region Örebro County • Aim: Prevention
Last updated Sep 03, 2026 00:00 UTC
-
New fibromyalgia drug AXS-14 enters final testing phase
Symptom relief Recruiting nowThe study is a Phase 3, double-blind, placebo-controlled, randomized withdrawal study to assess the efficacy and safety of AXS-14 in the management of fibromyalgia.
Phase 3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Could a 5-Minute nasal light zap stop surgical infections?
Prevention CompletedThis is a Phase 4 multi-center, group-randomized, crossover trial to compare nasal antimicrobial photodisinfection therapy (aPDT) with standard of care for prevention of surgical site infections in patients undergoing major elective, urgent, or emergent surgeries in a hospital se…
Sponsor: Ondine Biomedical Inc. • Aim: Prevention
Last updated Jun 27, 2026 12:32 UTC
-
New combo therapy aims to shrink prostate cancer tumors
Disease control Recruiting nowThe purpose of the study is to evaluate the safety, tolerability, and efficacy of the two different treatment combinations of tulmimetostat in participants with de novo or recurrent Metastatic Hormone-Sensitive Prostate Cancer (mHSPC).
Phase 1/2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New drug trial aims to ease droopy eyelids and double vision
Disease control Recruiting nowThis is a Phase III, multicenter, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of Telitacicept for the treatment of Ocular Myasthenia Gravis (OMG).Approximately 120 eligible subjects aged 12 to 80 years with a diagnosis of OMG (M…
Phase 3 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
First gene therapy trial launches for rare childhood disease MLIV
Disease control By invitation onlySafety and Efficacy of AAV9.hMCOLN1co for patients with Mucolipidosis Type IV(MLIV): A Single-Center, Interventional, Open-Label, Single-Arm Clinical Study. The goal of this clinical trial is to evaluate whether a gene therapy can safely treat children with MLIV.
Phase 1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New cholera vaccine trial aims to protect families in High-Risk areas
Vaccine Recruiting nowThis phase II study is intended to determine the immunogenicity and safety of single dose and two doses of OSP:rTTHc cholera conjugate vaccine (CCV) with or without alum adjuvant. The study will guide the future dosing schedule and formulation of CCV (with or without Aluminum pho…
Phase 2 • Sponsor: International Vaccine Institute • Aim: Vaccine
Last updated Jun 27, 2026 12:03 UTC
-
Low-Dose radiation plus immunotherapy shows promise for Tough-to-Treat nasopharyngeal cancer
Disease control Recruiting nowThis study aims to evaluate the efficacy and safety of LDRT combined with toripalimab and GP chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma through a prospective, open-label, single-arm Phase II clinical trial.
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Lung valves could starve Drug-Resistant TB cavities
Disease control Not yet recruitingTuberculosis (TB) is a complex disease in which the lungs are the primary site of infection. Infection is acquired through inhalation of droplet nuclei laden with Mycobacterium bacilli (M. tuberculosis) that settle in the alveoli as the primary focus. TB is characterized by a gra…
Sponsor: Azienda Ospedaliero-Universitaria Careggi • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New stroke drug combo aims to boost recovery in major trial
Disease control Not yet recruitingThe investigators propose to assess the efficacy and safety of intravenous tirofiban after bridging therapy (endovascular therapy \[EVT\] following intravenous Tenecteplase) for acute ischemic stroke due to intracranial atherosclerotic disease related large vessel occlusion (ICAD…
Phase 3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New combo shot study: could VAX-31 plus flu vaccine be a Game-Changer for seniors?
Prevention OngoingThis is a Phase 3, randomized, double-blind study to evaluate the safety and immunogenicity of VAX-31 and seasonal influenza vaccine in pneumococcal-naïve adults ≥ 50 years when the two vaccines are administered at the same visit or separately.
Phase 3 • Sponsor: Vaxcyte, Inc. • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC
-
New Shot-in-Tumor combo aims to beat melanoma before surgery
Disease control Recruiting nowThe success of anti-PD-1 and anti-CTLA-4 therapies has initiated a paradigm shift in oncology, with drugs now targeting the immune system rather than cancer cells to stimulate the antitumor immune response. Intratumoral (IT) delivery of immunostimulating agents reduces the system…
Phase 2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could breathing hydrogen protect the aging brain?
Symptom relief Recruiting nowAn open-label, one-arm, single-center clinical study tested safety and efficacy of one hour daily dosage of H2 gas in a form of inhalation. Dosage is administered during morning hours every working day according to detailed instructions to study participants. Primary objective: …
Phase 2 • Sponsor: University of Ostrava • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
New combo therapy hopes to tackle childhood brain tumors
Disease control Recruiting nowThis is a 3-part open-label study (feasibility phase, treatment phase and follow-up phase) of orally administered mirdametinib in combination with intravenous vinblastine chemotherapy in patients with PLGG with activation of MAPK pathway. Feasibility Phase: The maximum tolerate…
Phase 1/2 • Sponsor: St. Justine's Hospital • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Video games as therapy: VR may boost balance in teens with cerebral palsy
Disease control Recruiting nowThis randomized controlled trial aims to compare the effectiveness of fully immersive Mixed Reality (MR) combined with standard physical therapy versus standard physical therapy alone in improving balance and coordination among adolescents with spastic diplegic cerebral palsy. A …
Sponsor: Ibadat International University, Islamabad • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Smartphone heart check: could your phone save your life?
Diagnosis Recruiting nowHeart valve diseases are among the most serious cardiovascular conditions in older age. One of the most common forms is aortic valve stenosis, a narrowing of the valve opening between the left ventricle and the main artery. As the valve becomes tighter, the heart must work harder…
Sponsor: Medical University Innsbruck • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC
-
New pill could tame tough psoriasis without injections
Disease control Recruiting nowThis study is a randomized, double-blind, placebo- and active-controlled multicenter clinical trial involving patients with moderate to severe plaque psoriasis. Safety and efficacy assessments will be conducted during the scheduled study visits throughout the trial. After comple…
Phase 3 • Sponsor: InventisBio Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC